Edilytics

📍 Cambridge, United States🗓 Founded 2019👥 4 employees
Biotechnology Research🌐 edilytics.com
Website LinkedIn
Genome editing is transforming the way biological science is done and accelerating medical breakthroughs. CRISPR technology has reduced the barrier to creating predictable changes to DNA, encouraging scientific investigators and entrepreneurs to adopt and use the technology. However, robust and rigorous computational tools are critical for the correct analysis, interpretation and verification of biological results. We build precision algorithms for analyzing genome editing experimental data, and provide customized computational support to address critical questions in the processing of next-generation sequencing data. Please get in touch with us to get more information or to start a collaboration.
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Edilytics founded?
Edilytics was founded in 2019.
What industry is Edilytics in?
Edilytics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Edilytics based?
Edilytics is headquartered in Cambridge, United States.